Solasia Pharma K.K. (TYO:4597)
Japan · Delayed Price · Currency is JPY 33.00
0.00 (0.00%)
At close: Mar 27, 2026
Solasia Pharma K.K. Market Cap
Solasia Pharma K.K. has a market cap or net worth of 8.89 billion as of March 27, 2026. Its market cap has increased by 10.13% in one year.
Market Cap
8.89B
Enterprise Value
7.59B
Revenue
429.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.00
Market Cap Chart
Since March 24, 2017, Solasia Pharma K.K.'s market cap has decreased from 22.86B to 8.89B, a decrease of -61.13%. That is a compound annual growth rate of -9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.89B | 17.48% |
| Dec 30, 2025 | 7.56B | -3.61% |
| Dec 30, 2024 | 7.85B | 3.52% |
| Dec 29, 2023 | 7.58B | -7.91% |
| Dec 30, 2022 | 8.23B | -42.39% |
| Dec 30, 2021 | 14.29B | 0.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.60B |
| Pharma Foods International | 20.33B |
| Taiko Pharmaceutical | 15.28B |
| Wakamoto Pharmaceutical | 12.39B |
| Morishita Jintan | 9.55B |
| SymBio Pharmaceuticals | 7.61B |
| MedRx | 7.01B |
| WDB coco | 6.34B |